We compared the efficacy of preoperative intramuscular lornoxicam and ketoprofen for post-operative analgesia in patients undergoing abdominal hysterectomy. This randomized, double-blind, placebo-controlled, parallel-group study investigated 60 patients who received lornoxicam (group L, 8 mg), ketoprofen (group K, 100 mg) or saline (group C) 60 min before standard anaesthesia. All patients received patient-controlled analgesia (intravenous morphine) during the post-operative period. Visual analogue scale (VAS) scores recorded 2, 4, 6 and 12 h after surgery in groups L and K patients were significantly lower than in group C patients, and VAS scores at 2, 4 and 6 h in group L patients were significantly lower than those in group K patients. Morphine consumption in groups L and K was significantly lower than in group C. Pre-emptive administration of lornoxicam and ketoprofen effectively reduced post-operative pain and morphine consumption, and lornoxicam was more effective than ketoprofen in the early post-operative period.
Introduction
The use of a single analgesic to treat moderate to severe post-operative pain has proved inadequate to ensure optimal analgesia. Multi-modal analgesia is currently recommended for effective post-operative pain control. 1 Multi-modal analgesia is achieved by combining different analgesics that act by different mechanisms (e.g. opioids, non-steroidal anti-inflammatory drugs [NSAIDs] and local anaesthetics) and has fewer side-effects. 2 The use of multimodal analgesia decreases pain scores and/or the requirement for post-operative analgesics in different surgical procedures. 2 NSAIDs are commonly administered as adjuvant therapy during the pre-operative period because of their ability to improve the control of post-operative pain while reducing the need for opioid analgesics. 1 However, the possible pre-emptive analgesic effect of NSAIDs is currently under debate.
Lornoxicam is a new thienothiazine derivative of the oxicam class of NSAIDs.
In animal studies, lornoxicam demonstrated cyclo-oxygenase inhibitory activity approximately 100 times more powerful than that of tenoxicam, and analgesic activity approximately ten times greater than that of either tenoxicam or piroxicam. 3 In contrast to other oxicams, lornoxicam has a short plasma half-life, of approximately 4 -6 h. 3 This may translate into a better tolerability profile for lornoxicam, since NSAIDs with long plasma half-lives have been associated with a higher incidence of adverse effects. 3 Ketoprofen, a phenylpropionic acid derivative NSAID, inhibits nociceptive transmission through blockage of the cyclooxygenase pathway in both damaged tissue and spinal neurons; it also acts, through kynurenic acid, as an N-methyl-D-aspartate (NMDA) receptor antagonist. 4, 5 Because its onset of action is 55 -60 min and its plasma half-life is short (2 -2.5 h), ketoprofen is considered to be safer than other NSAIDs in the post-operative period. 6 To our knowledge, no previous controlled study has assessed the effects of lornoxicam or ketoprofen in patients after abdominal hysterectomy. We therefore performed a prospective, double-blinded, randomized, controlled study in patients undergoing abdominal hysterectomy. Our objectives were: (i) to compare the efficacy of lornoxicam and ketoprofen in terms of pain relief and their opioid-sparing effects; and (ii) to evaluate their tolerability.
Patients and methods

PATIENT POPULATION
Patients aged 30 -60 years, scheduled for abdominal hysterectomy and with an ASA physical status of I or II, were eligible for inclusion in the study. 7 Patients were excluded if they had a history of severe hepatic, renal, gastric or coagulative disease, or if they had received analgesic drugs within 2 weeks before surgery. The study was conducted in accordance with the ethical principles of the current amended version of the Declaration of Helsinki and was approved by the Ege University Ethical Committee (Ege University, Izmir, Turkey). All patients gave written informed consent the day before surgery.
STUDY DESIGN
This was a randomized, double-blind, placebo-controlled, parallel-group study. Patients were randomly allocated by a computer-generated randomization list to one of three treatment groups: lornoxicam 8 mg (group L); ketoprofen 100 mg (group K); and saline (group C). A single dose of the appropriate study medication was administered by intramuscular (IM) injection 60 min before induction of standard anaesthesia. All medicines were prepared by a nurse who had no other involvement in the study. None of the patients and managing anaesthetists knew the randomization code.
CLINICAL ASSESSMENTS
One day before the operation, patients received instructions about the use of a patient-controlled analgesia (PCA) device (APM ® , Abbott Laboratories, North Chicago, IL, USA) and a visual analogue scale (VAS) for pain. This scale consisted of an unmarked 10 cm line on which 0 cm represented no pain and 10 cm represented the worst pain imaginable.
After oral pre-medication with diazepam 5 mg, general anaesthesia was induced with 2 μg/kg fentanyl and 2 mg/kg propofol. Tracheal intubation was facilitated by 0.1 mg/kg vecuronium. All patients were mechanically ventilated with an equal mixture of oxygen and nitrous oxide.
Mechanical ventilation parameters were adjusted to obtain end-tidal carbon dioxide pressure in the 30 -35 mmHg range. Anaesthesia was maintained with 1 -2% sevoflurane/fentanyl 1 μg/kg according to 20% variation in blood pressure and/or heart rate compared with basal values. Tracheal extubation was carried out at the end of surgery after reversal of residual neuromuscular block. Patients received supplementary nasal oxygen after tracheal extubation.
In the post-operative care unit, all patients had access to intravenous (IV) analgesia by means of a PCA device containing morphine 0.4 mg/ml. The settings of the PCA device were as follows: loading dose of 5 mg; demand dose of 1 mg; no continuous background infusion; lockout time of 20 min; and no 4-h maximum. Pain was assessed using the VAS at 30 min and 2, 4, 6, 12 and 24 h after surgery. Patients were given additional analgesic (lornoxicam 8 mg IM or ketoprofen 100 mg IM) when analgesia was inadequate (VAS > 3). The total amount of morphine consumption was recorded 24 h after surgery.
ADVERSE EVENTS AND PATIENT SATISFACTION
Patients were evaluated for the presence of adverse events such as nausea, vomiting, dizziness, drowsiness, sedation, anxiety, dyspepsia, pruritus and indigestion. Nausea was evaluated using a two-point scale: 0 = absent; 1 = positive. Metoclopramide was given in case of vomiting or after two successive episodes of nausea. The degree of sedation was rated on a four-point scale: 0 = awake; 1 = drowsy; 2 = asleep but can be roused; and 3 = asleep and unable to be roused. To assess patient satisfaction, the patients were asked 'How effective was your medication in relieving your pain?' A five-point verbal rating scale (1 = excellent, 5 = very poor) that has been shown to have discriminatory power was used. 5
STATISTICAL ANALYSIS
Post-operative morphine consumption was used as the main criterion for statistical analysis. We calculated that it would be necessary to have 20 patients in each group in order to assess a 20% decrease in morphine consumption for treatment groups with an α risk of 0.05 and a β risk of 0.20. Demographic characteristics were analysed using Student's t-test, and the VAS pain scores and PCA morphine usage were analysed using Fisher's exact test. The χ 2 test was used to analyse the frequency of nausea, vomiting or pruritus. Statistical analysis was performed using SPSS version 10.0 for Windows (SPSS Inc., Chicago, IL, USA). A P-value < 0.05 was considered statistically significant.
Results
A total of 60 patients were randomly allocated to the three groups: lornoxicam 8 mg IM (group L; n = 20); ketoprofen 100 mg IM (group K; n = 20); and saline IM (group C; n = 20). There were no significant differences between the groups regarding age, body weight and duration of surgery (Table 1 ).
There were no significant differences in VAS scores 30 min and 24 h after surgery in all treatment groups. VAS scores 2, 4, 6 and 12 h after surgery in groups L and K patients were significantly lower than those in group C patients (P < 0.05), while VAS scores 2, 4 and 6 h after surgery in group L patients were significantly lower than those in group K patients (P < 0.05) ( Table 2) .
Morphine consumption in groups L and K patients was significantly lower than in group C patients (P < 0.05) from 2 to 24 h after surgery (Table 3) . Although morphine consumption was significantly lower in NSAIDs and post-operative morphine consumption group L patients than in group K patients 4 and 6 h after surgery (P < 0.05), there was no significant difference in the total morphine consumption between the two groups.
Adverse events observed during the study and patient satisfaction are summarized in severe or serious adverse events were reported. There were no significant differences in the incidence of adverse events between the three treatment groups. Most patients rated the control of analgesia as good.
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Discussion
This study demonstrated that pain relief following abdominal hysterectomy was controlled more effectively by the addition of pre-operative lornoxicam or ketoprofen than by pre-operative saline administration, and that lornoxicam more effectively reduced pain and morphine consumption than ketoprofen in the early post-operative period.
Studies on the pre-emptive analgesic effects of NSAIDs have reported contradictory results, although pre-emptive analgesic efficacy with NSAIDs has been established clinically and experimentally. 4, 8, 9 Lornoxicam and ketoprofen are NSAIDs that block constitutive cyclo-oxygenase (COX-1) and inducible cyclo-oxygenase (COX-2) activity. 10 As a consequence, they inhibit the production of prostaglandins and reduce the development of the sensitization process. 10 The antinociceptive and anti-inflammatory actions of NSAIDs may be related to the inhibition of nitric oxide synthase activation, reduced production of pro-inflammatory cytokines (through their inhibitory action on the nuclear factor NF-κB) and activation of lipoxins (endogenous anti-inflammatory mediators). 11 Consequently, the multidirectional action of NSAIDs suggests that it might be possible to modify the nociception process by the use of these drugs to induce pre-emptive analgesia in the peri-operative period.
Our results demonstrated that preoperative single-dose lornoxicam and ketoprofen reduced VAS pain scores and morphine consumption in the post-operative period. A similar benefit was previously demonstrated when NSAIDs were added to opioids, which resulted in reduced consumption of opioids. 3, 6, 12, 13 Lornoxicam improved the quality of post-operative analgesia and reduced the consumption of opioid analgesics. 12 Ilias and Jansen. 3 reported that pre-operative administration of lornoxicam (8 mg) produced an analgesic effect equal to that of tramadol (50 mg) and was better tolerated. Similar effects have been demonstrated for ketoprofen. Likar et al. 13 showed significant pre-emptive effects with ketoprofen, both in terms of the time to first analgesic request and by the lower analgesic consumption in the first 24 h after surgery. Aubrun et al. 6 reported that ketoprofen reduced morphine requirements and improved post-operative analgesia in patients undergoing major spinal surgery.
When the two treatment groups were compared, we found that lornoxicam reduced the pain intensity and morphine consumption in the early post-operative period more effectively than ketoprofen, but it should be noted that there was no difference in the total morphine consumption and pain scores in the later post-operative period. The difference between the elimination halflives of lornoxicam and ketoprofen (4 -6 h and 2 -2.5 h, respectively) may be the reason for this result.
Nausea and vomiting have been reported in previous studies with both lornoxicam and ketoprofen. 4 -6,12 However, a number of other factors have been shown to contribute to these events, including the administration of anaesthetic agents, surgical procedures and anaesthetic techniques, hypotension, and a previous history of post-operative nausea and motion sickness. 3 Also, the administration of opioids with a PCA system can aggravate post-operative nausea and vomiting. 14 Kokki et al. 15 reported that continuous IV ketoprofen improved postoperative pain and reduced epidural sufentanil requirements. However, the incidence of opioid-related adverse effects did not change. In the present study, although nausea and vomiting were observed more frequently in the placebotreated group (group C, saline IM), the S Karaman, I Gunusen, M Uyar et al. NSAIDs and post-operative morphine consumption differences were not statistically significant. It should be noted that the pre-operative administration of lornoxicam or ketoprofen was accompanied by a lower incidence of nausea and vomiting, which was probably linked to the lower consumption of morphine and better pain control.
Non-steroidal anti-inflammatory drugs inhibit biosynthesis of thromboxane A2. 16 Reduced production of thromboxane A2 prevents platelet aggregation and may increase blood loss during and after surgery. NSAIDs decrease platelet aggregation and increase bleeding time and thus may increase peri-operative and post-operative bleeding. 17 Rogers et al. 18 found that intraoperative median blood loss in patients receiving ketorolac before laparoscopic gynaecological surgery exceeded that of patients who received it after surgery. In their study of the analgesic efficacy of diclofenac after major abdominal surgery, Hodsman et al. 19 reported on two diclofenac-treated patients who underwent abdominoperitoneal resection of the rectum with extensive pelvic dissection. Both patients developed postoperative bleeding and required re-operation. However, studies using lornoxicam and ketoprofen have not detected problems with surgical bleeding, bleeding time, blood transfusion requirements or post-operative bleeding. 4 -6,12 In our study, there were no cases of excessive bleeding in the lornoxicam-and ketoprofen-treated groups during the postoperative period, and none of the patients from either group required re-operation. Gastrointestinal complications (gastritis, ulcer perforation and bleeding, dyspepsia and indigestion) have been described with the chronic use of NSAIDs. 6 However, the risk of serious gastrointestinal adverse effects with NSAIDs is very low after short-term perioperative use. 4, 5 In this study, only one patient (in the ketoprofen-treated group) complained of dyspepsia.
The development of tissue necrosis at the injection site is a rare but serious complication of IM administration of drugs. Pain occurs at the time of injection, but tissue necrosis typically becomes apparent a few days later. A number of severe local reactions have been reported at injection sites in patients treated with IM diclofenac. 20 Also, in a series of animal studies concerning local tolerance of different NSAIDs, a similar development of a necrotic area was found when piroxicam and diclofenac were administered IM. In contrast, other drugs, including ketoprofen, were well tolerated. 20 In conclusion, administration of lornoxicam IM and ketoprofen IM was effective and produced similar reductions in post-operative pain and analgesic consumption in patients undergoing abdominal hysterectomy. Lornoxicam was more effective than ketoprofen in the early post-operative period.
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